Litcius/Paper detail

GLUT1 contributes to impaired epithelial tight junction in the late phase of acute lung injury

Haixiong Tang, Zemin Chen, Sudan Gan, Yan Liang, Hailing Zhang, Changyun Yang, Liqin Lin, Yubiao Guo, Shiyue Li, Jing Li, Lihong Yao

2023European Journal of Pharmacology10 citationsDOIOpen Access PDF

Abstract

Dysfunction of epithelial barrier is crucial for the development of acute lung injury (ALI). This study was aimed to evaluate the role of glucose transporter 1 (GLUT1) in dysregulation of epithelial tight junction in ALI. GLUT1 was inhibited with specific antagonists WZB117 or BAY876 to see the effects on epithelial tight junction in a well-established LPS-induced mouse ALI model as well as in vitro cultured epithelial cells. Pharmacological inhibition of GLUT1 with WZB117 at either a low or high dose had no effects on lung injury and inflammation 24 h after LPS challenge, but significantly decreased the pulmonary inflammatory responses induced by LPS at 72 h with a high dose, which was verified by treatment with BAY876. WZB117 or BAY876 also recovered the expression of epithelial tight junction proteins ZO-1 and occludin. In cultured BEAS-2B and A549 cells, LPS induced increased GLUT1 expression, accompanied by decreased expression of tight junction protein ZO-1 and occludin. Blockade of GLUT1 restored LPS-induced disruption of ZO-1 and occludin in BEAS-2B rather than A549. Taken together, our results showed that GLUT1 is responsible for dysfunction of epithelial tight junctions in the late phase of LPS-induced ALI.

Topics & Concepts

OccludinTight junctionGLUT1A549 cellInflammationCell biologyCancer researchChemistryLungMedicineImmunologyEndocrinologyBiologyInternal medicineGlucose transporterInsulinBarrier Structure and Function StudiesCancer-related molecular mechanisms researchImmune Response and Inflammation